Tianjin Lisheng Pharmaceutical (002393.SZ): Perindopril amlodipine tablets (I) and perindopril amlodipine tablets (III) have passed the application for market approval.

Tianjin Lisheng Pharmaceutical (002393.SZ) announces that the company's drug Perindopril Amlodipine tablets (Type I) and Perindopril Amlodipine tablets (Type III) have passed the application for market approval. The indications of the above products are: This product is used for monotherapy to control high blood pressure in adult patients who are not adequately controlled; or as an alternative therapy for patients whose condition is controlled under the combination therapy of perindopril and amlodipine at the same dose level for primary hypertension.